| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Marjie L Hard, Angela Wehr, Lisa von Moltke, Yangchun Du, Sarah Farwick, David P Walling, John Sonnenber. Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal Therapeutic advances in psychopharmacology. vol 9. 2020-10-01. PMID:31308935. |
pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil nanocrystal aripiprazole lauroxil (al), a long-acting injectable antipsychotic for the treatment of schizophrenia in adults, can be started with either 21 days of daily oral aripiprazole supplementation or a 1-day initiation regimen consisting of a single injection of a nanocrystal |
2020-10-01 |
2023-08-13 |
Not clear |
| Wei Zheng, Dong-Bin Cai, Xin-Hu Yang, Gabor S Ungvari, Chee H Ng, Zhan-Ming Shi, Mei-Ling Hu, Yu-Ping Ning, Yu-Tao Xian. Adjunctive aripiprazole for antipsychotic-related hyperprolactinaemia in patients with first-episode schizophrenia: a meta-analysis. General psychiatry. vol 32. issue 5. 2020-10-01. PMID:31673677. |
adjunctive aripiprazole for antipsychotic-related hyperprolactinaemia in patients with first-episode schizophrenia: a meta-analysis. |
2020-10-01 |
2023-08-13 |
Not clear |
| Dahlia Rosally Turangan, Bahagia Loebis, Surya M Husada, Nazli Mahdinasari Nasutio. Differences of Fasting Blood Glucose Level in People with Schizophrenia between Before and After Getting Aripiprazole Treatment. Open access Macedonian journal of medical sciences. vol 7. issue 16. 2020-10-01. PMID:31777615. |
differences of fasting blood glucose level in people with schizophrenia between before and after getting aripiprazole treatment. |
2020-10-01 |
2023-08-13 |
Not clear |
| Andreas Schreiner, Paul Bergmans, Pierre Cherubin, Ludger Hargarte. The effect of long-acting paliperidone palmitate once-monthly on negative and depressive symptoms in patients with schizophrenia switched from previous unsuccessful treatment with oral aripiprazole. Therapeutic advances in psychopharmacology. vol 7. issue 2. 2020-09-30. PMID:28255435. |
the effect of long-acting paliperidone palmitate once-monthly on negative and depressive symptoms in patients with schizophrenia switched from previous unsuccessful treatment with oral aripiprazole. |
2020-09-30 |
2023-08-13 |
Not clear |
| Katsumasa Muneoka, Nobuhisa Kanahara, Shou Kimur. Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases. SAGE open medical case reports. vol 5. 2020-09-30. PMID:28255444. |
switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases. |
2020-09-30 |
2023-08-13 |
Not clear |
| Santanu Nath, Sajjadur Rehman, Kamal Narayan Kalita, Aparajeeta Barua. Aripiprazole-induced skin rash. Industrial psychiatry journal. vol 25. issue 2. 2020-09-30. PMID:28659705. |
we report a case of skin rash that developed after starting aripiprazole in a male patient suffering from schizophrenia and which remitted after the drug was stopped. |
2020-09-30 |
2023-08-13 |
Not clear |
| Keiki Sakurama, Akito Kawai, Victor Tuan Giam Chuang, Yoko Kanamori, Miyu Osa, Kazuaki Taguchi, Hakaru Seo, Toru Maruyama, Shuhei Imoto, Keishi Yamasaki, Masaki Otagir. Analysis of the Binding of Aripiprazole to Human Serum Albumin: The Importance of a Chloro-Group in the Chemical Structure. ACS omega. vol 3. issue 10. 2020-09-30. PMID:30411049. |
aripiprazole (arp), a quinolinone derivative, is an atypical antipsychotic drug that is used in the treatment of schizophrenia. |
2020-09-30 |
2023-08-13 |
human |
| Rosaria Di Lorenzo, Paola Ferri, Michela Cameli, Sergio Rovesti, Chiara Piemont. Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting. Neuropsychiatric disease and treatment. vol 15. 2020-09-30. PMID:30662264. |
effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting. |
2020-09-30 |
2023-08-13 |
Not clear |
| Maryam Tariq, Muhammad Iqbal Afridi, Dua Saleem, Sarmad Pirzad. Catatonic Schizophrenia: Cases with Possible Genetic Predisposition. Cureus. vol 11. issue 4. 2020-09-30. PMID:31263634. |
the diagnosis of catatonic schizophrenia was made, and the patient was started orally on aripiprazole and lorazepam. |
2020-09-30 |
2023-08-13 |
Not clear |
| Maryam Tariq, Muhammad Iqbal Afridi, Dua Saleem, Sarmad Pirzad. Catatonic Schizophrenia: Cases with Possible Genetic Predisposition. Cureus. vol 11. issue 4. 2020-09-30. PMID:31263634. |
we here discuss a possible genetic predisposition to catatonic schizophrenia and its initial improvement with lorazepam and subsequent treatment with olanzapine proving to be more efficacious than aripiprazole. |
2020-09-30 |
2023-08-13 |
Not clear |
| Richard E Hodgso. Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting. ClinicoEconomics and outcomes research : CEOR. vol 11. 2020-09-30. PMID:31616168. |
antipsychotics are an effective treatment option for patients with schizophrenia and several long-acting injectables (lais), including risperidone, olanzapine, paliperidone, and aripiprazole are available in the uk. |
2020-09-30 |
2023-08-13 |
Not clear |
| Suneeta James, Chaya Kapugama, Mohammed Al-Uzr. Corrigendum to "Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia". Case reports in psychiatry. vol 2019. 2020-09-30. PMID:31637079. |
corrigendum to "use of aripiprazole long acting injection in negative symptoms of schizophrenia". |
2020-09-30 |
2023-08-13 |
Not clear |
| Hiroyuki Kamei, Yuki Homma, Ippei Takeuchi, Genta Hajitsu, Kaori Tozawa, Masakazu Hatano, Aiko Fukui, Manako Hanya, Shigeki Yamada, Nakao Iwat. Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 18. issue 1. 2020-09-30. PMID:31958905. |
acceptance of the deltoid muscle injection of aripiprazole long-acting injectable in the patients with schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masan. Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 18. issue 1. 2020-09-30. PMID:31958916. |
effectiveness and tolerability of switching to aripiprazole once monthly from antipsychotic polypharmacy and/or other long acting injectable antipsychotics for patients with schizophrenia in routine practice: a retrospective, observation study. |
2020-09-30 |
2023-08-13 |
Not clear |
| Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masan. Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 18. issue 1. 2020-09-30. PMID:31958916. |
this study was done for collection of real world data of aripiprazole once monthly (aom) in patients with schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Taro Kishi, Yuki Matsuda, Shinji Matsunaga, Tomohiko Mukai, Masatsugu Moriwaki, Hideaki Tabuse, Kiyoshi Fujita, Nakao Iwat. A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders. Neuropsychiatric disease and treatment. vol 12. 2020-09-29. PMID:27932884. |
a randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders. |
2020-09-29 |
2023-08-13 |
Not clear |
| Taro Kishi, Yuki Matsuda, Shinji Matsunaga, Tomohiko Mukai, Masatsugu Moriwaki, Hideaki Tabuse, Kiyoshi Fujita, Nakao Iwat. A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders. Neuropsychiatric disease and treatment. vol 12. 2020-09-29. PMID:27932884. |
there has been no direct comparison of aripiprazole and blonanserin for schizophrenia treatment. |
2020-09-29 |
2023-08-13 |
Not clear |
| Taro Kishi, Yuki Matsuda, Shinji Matsunaga, Tomohiko Mukai, Masatsugu Moriwaki, Hideaki Tabuse, Kiyoshi Fujita, Nakao Iwat. A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders. Neuropsychiatric disease and treatment. vol 12. 2020-09-29. PMID:27932884. |
we conducted a 24-week, rater-masked, randomized trial of aripiprazole (6-30 mg/d) vs blonanserin (4-24 mg/d) in schizophrenia patients who were not taking any antipsychotic medication for more than 2 weeks before enrollment (umin000011194). |
2020-09-29 |
2023-08-13 |
Not clear |
| Leslie Citrome, Yangchun Du, Peter J Weide. Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm. Neuropsychiatric disease and treatment. vol 15. 2020-09-29. PMID:31686823. |
assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm. |
2020-09-29 |
2023-08-13 |
Not clear |
| Leslie Citrome, Yangchun Du, Peter J Weide. Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm. Neuropsychiatric disease and treatment. vol 15. 2020-09-29. PMID:31686823. |
here, nnt, nnh, and lhh were used to evaluate the clinical usefulness of aripiprazole lauroxil in patients with an acute schizophrenia exacerbation. |
2020-09-29 |
2023-08-13 |
Not clear |